Abstract
Atherosclerosis is the commonest and most important vascular disease. Andrographolide (AND) is the main bioactive component of the medicinal plant Andrographis paniculata and is used in traditional medicine. This study was aimed to evaluate the antiatherogenic effect of AND against atherosclerosis induced by Porphyromonas gingivalis in White New Zealand rabbits. Thirty rabbits were divided into five groups as follows: G1, normal group; G2–5, were orally challenged with P. gingivalis five times a week over 12 weeks; G2, atherogenic control group; G3, standard group treated with atorvastatin (AV) 5 mg/kg; and G4 and G5, treatment groups treated with AND 10 and 20 mg/kg, respectively over 12 weeks. Serums were subjected to antioxidant enzymatic and anti-inflammatory activities, and the aorta was subjected to histological analyses. Groups treated with AND showed a significant reversal of liver and renal biochemical changes, compared with the atherogenic control group. In the same groups, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), total glutathione (GSH) levels in serum were significantly increased (P < 0.05), and lipid peroxidation (malondialdehyde (MDA)) levels were significantly decreased (P < 0.05), respectively. Furthermore, treated groups with AV and AND showed significant decrease in the level of VCAM-1 and ICAM-1 compared with the atherogenic control group. In aortic homogenate, the level of nitrotyrosine was significantly increased, while the level of MCP1 was significantly decreased in AV and AND groups compared with the atherogenic control group. In addition, staining the aorta with Sudan IV showed a reduction in intimal thickening plaque in AV and AND groups compared with the atherogenic control group. AND has showed an antiatherogenic property as well as the capability to reduce lipid, liver, and kidney biomarkers in atherogenic serum that prevents atherosclerosis complications caused by P. gingivalis.
Similar content being viewed by others
References
Al Batran R, Al-Bayaty F, Al-Obaidi MMJ, Abdulla MA (2013a) Acute toxicity and the effect of andrographolide on porphyromonas gingivalis-induced hyperlipidemia in rats. BioMed Res Int 2013:7
Al Batran R, Al-Bayaty FH, Al-Obaidi MMJ (2013b) In-vivo effect of andrographolide on alveolar bone resorption induced by porphyromonas gingivalis and its relation with antioxidant enzymes. BioMed research international 2013
Al-Aubaidy HA, Sahib HA, Mohammad BI, Hadi NR, Abas SM (2013) Antiatherosclerotic potential of aliskiren: its antioxidant and anti-inflammatory effects in rabbits: a randomized controlled trial. J Pharma Technol Drug Res 2:11
Al-Bayaty FH, Abdulla MA, Hassan MIA, Ali HM (2012) Effect of andrographis paniculata leaf extract on wound healing in rats. Nat Prod Res 26:423–429
Amroyan E, Gabrielian E, Panossian A, Wikman G, Wagner H (1999) Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine 6:27–31
Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S (1996) Periodontal disease and cardiovascular disease. J Periodontol 67:1123–1137
Bocan T, Bak Mueller S, Mazur MJ, Uhlendorf PD, Quenby Brown E, Kieft KA (1993) The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation. Atherosclerosis 102:9–22
Chen W, Tang F, Xie B, Chen S, Huang H, Liu P (2012) Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress. Eur J Pharmacol 674:359–364
Cohen DE, Anania FA, Chalasani N (2006) An assessment of statin safety by hepatologists. Am J Cardiol 97:S77–S81
Draper H, Hadley M (1989) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421–431
Fki I, Bouaziz M, Sahnoun Z, Sayadi S (2005) Hypocholesterolemic effects of phenolic-rich extracts of Chemlali olive cultivar in rats fed a cholesterol-rich diet. Bioorg Med Chem 13:5362–5370
Gibson FR, Yumoto H, Takahashi Y, Chou H-H, Genco CA (2006) Innate immune signaling and porphyromonas gingivalis-accelerated atherosclerosis. J Dent Res 85:106–121
GómezGarre D, Muñoz‐Pacheco P, González‐Rubio M, Aragoncillo P, Granados R, FernándezCruz A (2009) Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect. Br J Pharmacol 156:1218–1227
Hadi NR, Abdulkadhim H, Almudhafer A, Majeed SA (2013) Effect of vildagliptin on atherosclerosis progression in high cholesterol–fed male rabbits. Journal of Clinical & Experimental Cardiology
Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H (2003) Role of oxidative stress in atherosclerosis. Am J Cardiol 91:7–11
Holt SC, Kesavalu L, Walker S, Genco CA (1999) Virulence factors of porphyromonas gingivalis. Periodontology 20:168–238, 2000
Hwang S-J, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM, Boerwinkle E (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases the atherosclerosis risk in communities (ARIC) study. Circulation 96:4219–4225
Jurkovitz CT, Abramson JL, Vaccarino LV, Weintraub WS, McClellan WM (2003) Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol 14:2919–2925
Juźwiak S, Wójcicki J, Machoy-Mokrzyńska A, Samochowiec L, Biaecka M, Juzyszyn Z, Barcew-Wiszniewska B, Skowron J, Rózewicka L, Kadlubowska D (1996) Effect of lecithin on the development of experimental atherosclerosis in rabbits. Phytomedicine 2:199–204
Khor GL (2001) Cardiovascular epidemiology in the Asia–Pacific region. Asia Pac J Clin Nutr 10:76–80
Koyanagi M, Egashira K, Kitamoto S, Ni W, Shimokawa H, Takeya M, Yoshimura T, Takeshita A (2000) Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis. Circulation 102:2243–2248
Kudchodkar BJ, Pierce A, Dory L (2007) Chronic hyperbaric oxygen treatment elicits an anti-oxidant response and attenuates atherosclerosis in apoE knockout mice. Atherosclerosis 193:28–35
Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A (1995) Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 63:3878–3885
Ley K, Miller YI, Hedrick CC (2011) Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 31:1506–1516
Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6:508–519
Libby P (2012) Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32:2045–2051
Mainardi T, Kapoor S, Bielory L (2009) Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol 123:283–294, e210
Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drüeke TB (2005) Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 16:109–116
Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T (1999) Endogenous nitric oxide synthase inhibitor a novel marker of atherosclerosis. Circulation 99:1141–1146
Napoli C, Ignarro LJ (2001) Nitric oxide and atherosclerosis. Nitric Oxide 5:88–97
Neldner KH (2000) Complementary and alternative medicine. Dermatol Clin 18:189–193
O’Brien KD, Allen M, McDonald TO, Chait A, Harlan J, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin C (1993) Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Investig 92:945
Park JG (2011) Invited mini review: the role of peroxidases in the pathogenesis of atherosclerosis. Biochemi Mol Biol Rep 44:497–505
Prasad K, Mantha SV, Kalra J, Lee P (1997) Prevention of hypercholesterolemic atherosclerosis by garlic, an antioxidant. J Cardiovasc Pharmacol Ther 2:309–319
Rahman S, Van Dam A-M, Schultzberg M, Crisby M (2005) High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice. J Neuroimmunol 169:59–67
Schmitz G, Torzewski M (2001) Atherosclerosis: an inflammatory disease. Inflammatory and infectious basis of atherosclerosis. Springer, pp. 1-21
Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205
Tang L, Peng H, Xu T, Wang A, Wang G, Tong W, Zhang Y (2014) Association of biomarkers of inflammation with dyslipidemia and its components among Mongolians in China. PLoS One 9:e89023
Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363:1341–1350
Taylor F, Ward K, Moore T, Burke M, Davey S (2013) Statins for the primary prevention of cardiovascular disease. Cochrane database of systematic reviews 1
Wasman S, Mahmood A, Chua LS, Alshawsh MA, Hamdan S (2011) Antioxidant and gastroprotective activities of Andrographis paniculata (Hempedu Bumi) in Sprague Dawley rats
Xiangdong L, Yuanwu L, Hua Z, Liming R, Qiuyan L, Ning L (2011) Animal models for the atherosclerosis research: a review. Protein & Cell 2:189–201
Yang T, Hx S, Zt W, Wang C (2013) Hypolipidemic effects of andrographolide and neoandrographolide in mice and rats. Phytother Res 27:618–623
Yousef MI, Kamel KI, Esmail AM, Baghdadi HH (2004) Antioxidant activities and lipid lowering effects of isoflavone in male rabbits. Food Chem Toxicol 42:1497–1503
Yusuf S, Reddy S, Ôunpuu S, Anand S (2001) Global burden of cardiovascular diseases part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104:2746–2753
Zhang C, Tan B (1996) Hypotensive activity of aqueous extract of andrographis paniculata in rats. Clin Exp Pharmacol Physiol 23:675–678
Zhang XF, Tan BKH (2000) Antihyperglycaemic and anti-oxidant properties of andrographis paniculata in normal and diabetic rats. Clin Exp Pharmacol Physiol 27:358–363
Acknowledgments
The authors express gratitude to the Faculty of Dentistry, Universiti Teknologi Mara (UiTM) and the Faculty of Medicine, University of Malaya (UM). This study was financially supported by the Universiti Teknologi Mara (UiTM; grant no. 600-RMI/DANA 5/3 PSI (134/2013)).
Author contributions
RAB: experimental design, animal study, data collection, analysis, and interpretation; writing the manuscript and the decision to submit the manuscript for publication. FAB: experimental design and the decision to submit the manuscript for publication. RAB and AA: data interpretation and writing the manuscript. RAB and MMJ: data analysis and revision of the manuscript. All authors read and approved the final manuscript.
Conflict of interest
No competing interests of either a financial or nonfinancial in nature.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al Batran, R., Al-Bayaty, F., Al-Obaidi, M.M.J. et al. Insights into the antiatherogenic molecular mechanisms of andrographolide against Porphyromonas gingivalis-induced atherosclerosis in rabbits. Naunyn-Schmiedeberg's Arch Pharmacol 387, 1141–1152 (2014). https://doi.org/10.1007/s00210-014-1041-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-014-1041-x